Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Heart failure in 10 years time: focus on pharmacological treatment.

× No keyword cloud information.

58 in total

1. Changes in notions about heart failure.

Authors: M Petrie; J McMurray
Journal: Lancet Date: 2001-08-11 Impact factor: 79.321

2. Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure.

Authors: D B Northridge; P F Currie; D E Newby; J J McMurray; M Ford; N A Boon; H J Dargie
Journal: Eur J Heart Fail Date: 1999-03 Impact factor: 15.534

3. Effects of UK 69 578: a novel atriopeptidase inhibitor.

Authors: D B Northridge; A G Jardine; C T Alabaster; P L Barclay; J M Connell; H J Dargie; S G Dilly; I N Findlay; A F Lever; G M Samuels
Journal: Lancet Date: 1989-09-09 Impact factor: 79.321

Review 4. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines.

Authors: D L Mann; J B Young
Journal: Chest Date: 1994-03 Impact factor: 9.410

5. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995.

Authors: K MacIntyre; S Capewell; S Stewart; J W Chalmers; J Boyd; A Finlayson; A Redpath; J P Pell; J J McMurray
Journal: Circulation Date: 2000-09-05 Impact factor: 29.690

6. Protective effect of omapatrilat, a vasopeptidase inhibitor, on the metabolism of bradykinin in normal and failing human hearts.

Authors: C Blais; D Fortin; J L Rouleau; G Molinaro; A Adam
Journal: J Pharmacol Exp Ther Date: 2000-11 Impact factor: 4.030

7. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.

Authors: J L Rouleau; M A Pfeffer; D J Stewart; D Isaac; F Sestier; E K Kerut; C B Porter; G Proulx; C Qian; A J Block
Journal: Lancet Date: 2000-08-19 Impact factor: 79.321

8. Endothelin-receptor antagonists: current and future perspectives.

Authors:
Journal: Drug Discov Today Date: 2000-10-01 Impact factor: 7.851

9. Plasma endothelin in chronic heart failure.

Authors: J J McMurray; S G Ray; I Abdullah; H J Dargie; J J Morton
Journal: Circulation Date: 1992-04 Impact factor: 29.690

10. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy.

Authors: K Sliwa; D Skudicky; G Candy; T Wisenbaugh; P Sareli
Journal: Lancet Date: 1998-04-11 Impact factor: 79.321

1 in total

Review 1. Candesartan cilexetil: a review of its use in the management of chronic heart failure.

Authors: Caroline Fenton; Lesley J Scott
Journal: Drugs Date: 2005 Impact factor: 9.546

1 in total